PMID- 23547217 OWN - NLM STAT- MEDLINE DCOM- 20131210 LR - 20220408 IS - 1499-2752 (Electronic) IS - 0315-162X (Print) IS - 0315-162X (Linking) VI - 40 IP - 5 DP - 2013 May TI - urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. PG - 674-83 LID - 10.3899/jrheum.120879 [doi] AB - OBJECTIVE: Glomerulonephritis (GN) is common in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but tools for early detection of renal involvement are imperfect. We investigated 4 urinary proteins as markers of active renal AAV: alpha-1 acid glycoprotein (AGP), kidney injury molecule-1 (KIM-1), monocyte chemoattractant protein-1 (MCP-1), and neutrophil gelatinase-associated lipocalin (NGAL). METHODS: Patients with active renal AAV (n = 20), active nonrenal AAV (n = 16), and AAV in longterm remission (n = 14) were identified within a longitudinal cohort. Urinary biomarker concentrations (by ELISA) were normalized for urine creatinine. Marker levels during active AAV were compared to baseline remission levels (from 1-4 visits) for each patient. Areas under receiver-operating characteristic curves (AUC), sensitivities, specificities, and likelihood ratios (LR) comparing disease states were calculated. RESULTS: Baseline biomarker levels varied among patients. All 4 markers increased during renal flares (p < 0.05). MCP-1 discriminated best between active renal disease and remission: a 1.3-fold increase in MCP-1 had 94% sensitivity and 89% specificity for active renal disease (AUC = 0.93, positive LR 8.5, negative LR 0.07). Increased MCP-1 also characterized 50% of apparently nonrenal flares. Change in AGP, KIM-1, or NGAL showed more modest ability to distinguish active renal disease from remission (AUC 0.71-0.75). Hematuria was noted in 83% of active renal episodes, but also 43% of nonrenal flares and 25% of remission samples. CONCLUSION: Either urinary MCP-1 is not specific for GN in AAV, or it identifies early GN not detected by standard assessment and thus has potential to improve care. A followup study with kidney biopsy as the gold standard is needed. FAU - Lieberthal, Jason G AU - Lieberthal JG AD - Department of Medicine, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA. FAU - Cuthbertson, David AU - Cuthbertson D FAU - Carette, Simon AU - Carette S FAU - Hoffman, Gary S AU - Hoffman GS FAU - Khalidi, Nader A AU - Khalidi NA FAU - Koening, Curry L AU - Koening CL FAU - Langford, Carol A AU - Langford CA FAU - Maksimowicz-McKinnon, Kathleen AU - Maksimowicz-McKinnon K FAU - Seo, Philip AU - Seo P FAU - Specks, Ulrich AU - Specks U FAU - Ytterberg, Steven R AU - Ytterberg SR FAU - Merkel, Peter A AU - Merkel PA FAU - Monach, Paul A AU - Monach PA CN - Vasculitis Clinical Research Consortium LA - eng GR - RC1 AR058303/AR/NIAMS NIH HHS/United States GR - U01 AR051874/AR/NIAMS NIH HHS/United States GR - M01 RR000533/RR/NCRR NIH HHS/United States GR - K24 AR002224/AR/NIAMS NIH HHS/United States GR - RC1 AR0508303-01/AR/NIAMS NIH HHS/United States GR - U54 RR019497/RR/NCRR NIH HHS/United States GR - M01 RR001066/RR/NCRR NIH HHS/United States GR - UL1 TR000439/TR/NCATS NIH HHS/United States GR - U54 AR057319/AR/NIAMS NIH HHS/United States GR - U01 AR51874-0/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Multicenter Study PT - Research Support, N.I.H., Extramural DEP - 20130401 PL - Canada TA - J Rheumatol JT - The Journal of rheumatology JID - 7501984 RN - 0 (Acute-Phase Proteins) RN - 0 (Biomarkers) RN - 0 (Chemokine CCL2) RN - 0 (HAVCR1 protein, human) RN - 0 (Hepatitis A Virus Cellular Receptor 1) RN - 0 (LCN2 protein, human) RN - 0 (Lipocalin-2) RN - 0 (Lipocalins) RN - 0 (Membrane Glycoproteins) RN - 0 (Orosomucoid) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Receptors, Virus) SB - IM MH - Acute-Phase Proteins/urine MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications/*diagnosis/urine MH - Biomarkers/*urine MH - Chemokine CCL2/urine MH - Female MH - Glomerulonephritis/*diagnosis/etiology/urine MH - Hepatitis A Virus Cellular Receptor 1 MH - Humans MH - Lipocalin-2 MH - Lipocalins/urine MH - Male MH - Membrane Glycoproteins/urine MH - Middle Aged MH - Orosomucoid/urine MH - Predictive Value of Tests MH - Proto-Oncogene Proteins/urine MH - ROC Curve MH - Receptors, Virus MH - Recurrence MH - Time Factors MH - Young Adult PMC - PMC4505819 MID - NIHMS703967 OTO - NOTNLM OT - BIOMARKERS OT - GLOMERULONEPHRITIS OT - MONOCYTE CHEMOATTRACTANT PROTEIN-1 OT - VASCULITIS OT - WEGENER GRANULOMATOSIS EDAT- 2013/04/03 06:00 MHDA- 2013/12/16 06:00 PMCR- 2015/07/17 CRDT- 2013/04/03 06:00 PHST- 2013/04/03 06:00 [entrez] PHST- 2013/04/03 06:00 [pubmed] PHST- 2013/12/16 06:00 [medline] PHST- 2015/07/17 00:00 [pmc-release] AID - jrheum.120879 [pii] AID - 10.3899/jrheum.120879 [doi] PST - ppublish SO - J Rheumatol. 2013 May;40(5):674-83. doi: 10.3899/jrheum.120879. Epub 2013 Apr 1.